Dr Laurie Glimcher
Board of Directors
ReSearch Pharmaceutical Service
Singapore
Biography
GSK continue its appointment spree with a particularly notable staff acquisition, with leading immuno-oncology scientist, Dr Laurie Glimcher, joining its Board of Directors. It is becoming evident that new CEO, Emma Walmsley, is aiming to put her own stamp onto the company through a series of high-profile R&D appointments.
Research Interest
The new approach had a focus on immuno-oncology and it will attract a fair amount of interest across the industry that company has pushed the boat out to acquire an individual as notable in the field as Glimcher.
